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formation: eﬀect on the aggregation mechanism
and ﬁbril morphology†
Carlotta Marasini,*a Vito Fodera`b and Bente Vestergaard*a
Co-solutes, such as sugars, are used in in vitro protein aggregation experiments to mimic crowding and, in
general, complex environments. Sugars often increase the stability of the native protein structure by
aﬀecting inter- and intramolecular protein–protein interactions. This, in turn, modiﬁes the protein self-
assembly pathways. Using a combination of ﬂuorescence spectroscopy, synchrotron radiation circular
dichroism and transmission electron microscopy, we study the kinetics of formation and structural
properties of human insulin ﬁbrils in the presence of sucrose. The presence of sucrose results in a delay
of the onset of ﬁbrillation. Moreover, it leads to a dramatic change in both the morphology and overall
amount of ﬁbrils. Our results emphasize that the detailed composition of protein surroundings likely
inﬂuences not only the ﬁbrillation kinetics but also the balance between diﬀerent species, potentially
determining ﬁbril strains with diﬀerent biological activities. This aspect is crucial in the etiology of
pathologies associated with amyloidosis.Introduction
The environment in a living cell consists of a multitude of
components which co-exist in a soluble state at very high
concentrations.1 Proteins, RNA and DNA oen occupy 30–40%
of the entire volume.1–4 This both reduces the mobility and
modies the extent of the physico–chemical interactions
between macromolecules.5 In vitro, it is possible to mimic such
a complex environment by adding macromolecular crowding
agents (MCA). Typical agents are inert, un-charged and can be
of diﬀerent sizes (e.g. polysaccharides, dextran, sucrose, trime-
thylamine oxide). Osmolytes can act either as stabilizers or
destabilizers depending on whether the osmolyte is excluded or
accumulated around the protein backbone, i.e. preferential
hydration.6 Sucrose was used in several studies on the folding
and stability of, e.g. lysozyme,4 cytochrome C,7 RNase8 and
insulin.9 In all these cases the proteins tend to assume a more
folded and compact structure in the presence of sucrose.
Protein amyloid-like aggregation is related to devastating
pathologies as Alzheimer's and Parkinson's diseases. During
this process, the protein native state converts into a partially
unfolded non-native state and then associates into smaller,macology, University of Copenhagen,
nmark. E-mail: carlotta.marasini@sund.
Pharmacy, University of Copenhagen,
nmark
ESI) available: Supplementary data and
OI: 10.1039/c6ra25872g
hemistry 2017soluble oligomers of diﬀerent sizes. Subsequently, elongated
brils are formed (i.e. brillation). The initial formation of oligo-
meric species is considered to be a nucleated reaction,10–12 while
the formation of the elongated structures is also controlled by auto-
catalytic processes known as secondary nucleation processes.13,14
Importantly, monomers, oligomers, and brils coexist in an equi-
librium that is inuenced by the environment.15–17 In vivo, proteins
experience a naturally complex environment that aﬀects inter- and
intra-protein interactions. This may modify the brillation
process17,18 via changing both protein conformational stability and
the tendency to form complexes. As a consequence, the eﬀect of
MCA on the brillation reaction is expected to be multifacto-
rial. It acts both at the level of the reaction and the nal
structures, inuencing the complex equilibrium between the
diﬀerent structural species. This can determine the formation
of species with diﬀerent toxic potency and with various bio-
logical eﬀects.19,20 As a consequence, disentangling the
diﬀerent eﬀects of MCA on protein self-assembly processes is
crucial in the etiology of amyloid-related diseases. Some
general trends are evident from the existing literature on in
vitro experiments. MCA have diﬀerent eﬀects on the aggrega-
tion process of intrinsically disordered proteins (IDPs)21,22
compared to the one of (natively) folded proteins. In an
aggregation process, IDPs convert from a disordered state into
a relatively dened and aggregation-prone conformation.23
The latter is favored by the presence of MCA,7,24,25 making the
aggregation process more likely. In contrast, MCA prevent
a globular/folded protein to adopt a relatively unfolded state.
This, in turn, inhibits the self-assembly process. In the case of
IDPs, it has been shown that both the onset and the speed ofRSC Adv., 2017, 7, 10487–10493 | 10487
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View Article Onlinebrillation are enhanced in a complex environment.26–29 For
globular/folded protein there is evidence of either an
enhancement15,27 or inhibition of the brillation process.19,30–33
And nally, the eﬀect of chaperones on protein aggregation in
diﬀerent environments has been studied.34 The above studies
are focused on how and if a complex environment aﬀects the
brillation kinetics. On the contrary, an analysis of the bril
structural changes induced by MCA is still lacking, with only
few evidences reported in the literature.35
In this article, we aim to clarify how sucrose can aﬀect
structural and kinetic aspects of the amyloid bril formation in
the case of a natively globular protein. We used human insulin as
amodel system11,36,37 and wemonitored the brillation process in
the presence of sucrose using microscopy and spectroscopy
techniques. Previous studies suggest that sucrose favors a more
compact and folded state of native insulin.9,33 However, it is still
unclear how and if sucrose inuences the insulin brillation
kinetics and the morphology of the nal brils. We focus on the
overall eﬀect induced by sucrose (from 10 to 40% w/v) on both
the brillation kinetics and the bril morphologies. We highlight
an eﬀect on the temporal features of the kinetics. Moreover, our
data show that the structure of a soluble native-like species co-
existing with the mature brils is signicantly stabilized by the
presence of sucrose. This provides a proof of sucrose-induced
changes not only on the brillation kinetics but also on the
structural equilibria between the occurring species.Materials and methods
Materials and sample preparation
Thioavin T (ThT), recombinant human insulin (91077C) and all
other chemicals are obtained from Sigma, St. Louis, MO. Stock
solutions of 60% sucrose (w/v, 1.75 M) in 20% acetic acid, pH 1.8
are prepared weighting the correct amount of sucrose in a solu-
tion of 20% acetic acid (v/v) and used for making diluted solu-
tions at 45%, 30%, and 15% w/v sucrose. The diluted solutions
are stored at 18 C. Before each preparation, the sucrose solu-
tions are thawed, heated and ltered at 80 C using a 0.22 mm
syringe lter (Ministart, 16534 Sartorius). The nal concentration
of sucrose is further evaluated by monitoring the mass per
volume, as well as the refractive index measured by an optical
refractometer (data not shown). A protein stock solution is ob-
tained by dissolving the insulin powder at a concentration of
20mgml1 in 20% acetic acid, 0.03MNaCl, pH 1.8. The solution
is ltered using a 0.20 mmspin lter (UFC30GV00,Millipore). The
concentration is determined by absorption at 280 nm (extinction
coeﬃcient of 1.0675 cm1) measured by using a Nanodrop UV-vis
spectrophotometer (Thermo Scientic). From this stock solution,
insulin samples at a nal concentration of 5 mg ml1 insulin,
20% acetic acid, pH 1.8, 10 mM NaCl and 0, 10, 20, 30 and 40%
w/v of sucrose are prepared. Here aer, % of sucrose always
indicates % w/v of sucrose.Fibrillation assays
Fibrillation is thermally induced and monitored by in situ ThT
(20 mM).38,39 Fluorescence is detected using a Fluostar Optima10488 | RSC Adv., 2017, 7, 10487–10493plate reader (BMG labtech) in 96-well optical bottom plates
(Thermo Scientic). 150 ml is the total volume for each well and
samples are incubated at 60 C or 45 C without shaking. The
measurements are carried out at an excitation wavelength of
450 nm, and the ThT emission is recorded at 480 nm (using
5 nm excitation and emission bandwidth). Fibrils are collected
aer the ThT uorescence intensity reaches the plateau value
for the imaging analysis.
Experiments on sonicated samples (aer brillation) are
performed at 30 C in the plate reader for 24 hours. The brils
are sonicated for 1 minute using a micro-sonicator Sonopuls
from Bandelin, setting the intensity to 50% with 30 pulses at
0.1 s frequency. 20 mMof ThT are added, and the uorescence is
followed during 24 hours.
The ThT signal is recorded as a function of the incubation
time and is normalized by the average of the uorescence value
in the plateau. Temporal proles are described using two
parameters the time at which insulin brillation initiated (lag
time) and the ThT uorescence nal value (FFV).40,41 The data
presented are an average of 20 diﬀerent curves, for each sucrose
concentration, recorded from ve diﬀerent experiments.Transmission electron microscopy
Grids are prepared as described by Smith and co-workers.40
Briey, 5 ml of the sample (0.5 mg ml1) are loaded onto copper
400 mesh grids (Agar Scientic, Stansted, UK) coated with
Formvar and carbon lm. Aer 60 s, 10 ml of distilled water is
added, and excess water is removed. Subsequently, 10 ml of 2%
(v/v) uranyl acetate (Agar Scientic) is placed on the grid and le
for 30 s. Finally, 2  10 ml distilled water are added and again
excess water is removed. The grid is then le to dry. Images are
acquired at the Core Facility for Integrated Microscopy (CFIM),
at the Department of Health andMedical Sciences, University of
Copenhagen. Images are collected using a CM100 transmission
electron microscope operating at an acceleration voltage of 80
kV. The program ImageJ is used for performing a statistical
analysis of the bril dimensions. Twenty diﬀerent images are
analyzed to estimate radius and clustering parameters. The
statistical ensemble for the imaging analysis consists of a total
number of 200 brils for each sucrose concentration, made in 3
diﬀerent sample preparations.Synchrotron radiation circular dichroism (SRCD)
The measurements are performed at the Aarhus University, CD
beam line on ASTRID2. Samples are measured at an insulin
concentration of approximately 5 mg ml1 using a cuvette with
a path length of 16 mm. The short path length enables a rela-
tively high protein concentration, thereby allowing for direct
comparison between CD spectra and ThT uorescence obser-
vations. Ellipticity is monitored at wavelengths from 170 nm to
280 nm. The ellipticity at each wavelength is measured 15 times
and averaged automatically. Several spectra are recorded over
around 20 minutes for checking the stability of the signal over
time. The spectra are then averaged and normalized to the
concentration including only curves where the protein structureThis journal is © The Royal Society of Chemistry 2017
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View Article Onlineis stable. All spectra are smoothed using the Savitzky–Golay
algorithm.42Results and discussion
Eﬀect of sucrose on the human insulin brillation kinetics
Using the same approach as previously described,38,39 in situ
ThT uorescence is measured for monitoring the amyloid
aggregate formation at 60 C of 5 mgml1 human insulin at ve
diﬀerent sucrose concentrations: 0%, 10%, 20%, 30% and 40%
(black, green, red, pink and blue respectively in Fig. 1a). In all
cases, a clear sigmoidal trend is observed. FFV is the uores-
cence value at the plateau (approx. 5 hours) and, at the insulin
concentration investigated here, it can be related to the overall
amount of brils formed.37 Additionally, we determined the lag
time calculated as the time at which the uorescence ThT signal
has increased to 10% of the FFV.41
Data in Fig. 1 suggest that sucrose changes the brillation
kinetics. Upon increasing the sucrose concentration, the lag
time increases, indicating that sucrose delays the onset of the
bril formation (Fig. 1b). Longer lag times could reect a partial
suppression of primary nucleation.43,44 This step is dependent
on at least two factors: (1) the distribution of conformations, i.e.
folded or (partially) unfolded vs. nucleation-prone, and (2) the
diﬀusion of these molecules in solution determining the rate of
interactions betweenmolecules. Sucrose maymodify both these
factors.
The FFV values change signicantly in the presence of
sucrose (Fig. 1c). This can be due to (i) a reduced sensitivity of
the ThT assay due to the presence of sucrose or (ii) a direct eﬀect
of sucrose on the bril formation. In the rst scenario, one
possibility can be that sucrose interferes with the ThT signal.
Sucrose molecules could indeed either organize themselves
around or directly interact with the protein brils, therebyFig. 1 (a) Fibrillation of human insulin in 20% acetic acid, pH 1.8,
10 mM NaCl at diﬀerent concentrations of sucrose: 0% (black line),
10% (green line), 20% (red line), 30% (pink line) and 40% (blue line).
Each curve is an average (with standard deviation as an error) of at least
5 experiments where 20 diﬀerent wells are recorded for each sucrose
concentration. Two parameters are quantiﬁed (see Materials and
methods) from the curves in panel a as a function of the amount of
sucrose: (b) the lag time and (c) the ﬁnal ﬁbrils value (FVV) with a full line
as a guide for the eyes. In both panel (b) and (c) each point is the
average (with a standard deviation) of the value obtained from six
independent experiments.
This journal is © The Royal Society of Chemistry 2017excluding the ThT molecules from the bril accessible surfaces
and hence reducing the uorescence values.45,46 Alternatively,
the drop of the FFV can be due to an increased tendency of the
brils to cluster at increasing sucrose concentrations.47 The
surface of brils is less exposed in a cluster; this reduces the
possibility for ThT to bind to the cross-b structure and decreases
the uorescence signal.47–49 A nal explanation can be that the
presence of sucrose eﬀectively reduces the quantity of formed
brils. Our further investigations enable a distinction between
these scenarios.Sucrose aﬀects the bril morphology and tendency of
clustering
A morphological investigation of the samples can highlight
potential macroscopic structural diﬀerences and the overall
extent of brillation. The Transmission Electron Microscopy
(TEM) images in Fig. 2 show that brils are formed in all
samples. However, as highlighted in Fig. 2 (colored squares),
diﬀerent morphologies can be observed as a function of the
sucrose concentration.
In the absence of sucrose, the brils have the typical helical
twist morphology as observed for most amyloid brilsFig. 2 Representative TEM (a–c) images of insulin ﬁbrils formed in
presence of diﬀerent amounts of sucrose: (a) 0% (black), (b) 20% (red)
and (c) 40% (blue). Scale bars are 200 nm. The colored boxes in panels
(a–c) indicate the areas acquired at higher resolution (right column).
Magniﬁcations highlight the diﬀerent morphologies: insulin ﬁbrils with
a twisted helices morphology, straight parallel wires, and ribbon-like
macroscopic structure.
RSC Adv., 2017, 7, 10487–10493 | 10489
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View Article Online(Fig. 2a).10,50 In the presence of 20% sucrose, brils become
longer and linear and align in pairs (Fig. 2b). This is in accor-
dance with a previous report.35 If the concentration of sucrose is
40%, brils are isolated, rather than clustered, with
a pronounced length up to 10 mm (Fig. 2c). These brils are also
less linear than the brils formed in 20% sucrose (additional
examples of these diﬀerent morphologies are shown in Fig. S1
in the ESI†). We estimated the section diameters of 200 brils
for each sample using the program ImageJ (Fig. 3a). A decrease
of the bril section diameter is obtained already at 20% sucrose
(Fig. 3a), and then is maintained at 40% sucrose (Table 1). As
shown in Table 1 the number of isolated brils increases upon
increasing the amount of sucrose. These data reject the
hypothesis that the decreasing of the FFV at 40% sucrose may
be due to a quenching of the uorescence signal determined by
bril clustering.47
To verify the suggestion from the TEM data in Fig. 2a–c and
Table 1, brils were sonicated (see Materials and methods), and
the ThT uorescence values were detected before and aer the
treatment. If there is a signicant bril cluster formation, the
mechanical disruption would likely lead to a more eﬃcient ThT
staining of the single brils, i.e. an increase of ThT accessibility
to the brils and ThT uorescence signal.47,51 On the contrary, if
sucrose is not aﬀecting the bril clustering, the sonication will
have a minor eﬀect, if any. As shown in Fig. 3b, at 40% sucrose
no signicant diﬀerence in the uorescence intensity before
and aer the sonication is detected (light and dark blue
column, respectively). On the contrary, in the absence of
sucrose and at 20% sucrose, an increase of 45% and 28% of theFig. 3 (a) Diameters of the ﬁbril section formed in the presence of 0%
(black column), 20% (red colour) and 40% (blue colour) sucrose (see
Materials and methods), (b) ThT ﬂuorescence signal of ﬁbrils formed in
a diﬀerent amount of sucrose, the colour code as in (a) before (light
column) and after gentle sonication (dark column).
Table 1 TEM image statistical analysis of the clustering of insulin ﬁbrils
formed in the presence of diﬀerent amounts of sucrose: 0%, 20% and
40%. For 200 ﬁbrils, made in 3 diﬀerent sample preparations, the
frequency of occurrence for single ﬁbrils and clusters with two or
more ﬁbrils is calculated using the program ImageJ
Sample Single brils
Clusters
(2 brils)
Clusters
(>2 brils)
0% sucrose 88% 10% 2%
20% sucrose 96% 4% 0%
40% sucrose 98% 2% 0%
10490 | RSC Adv., 2017, 7, 10487–10493signal is observed aer sonication, respectively. Data in Fig. 3b
corroborate the image analysis performed (Table 1) and shows
that clustering mainly takes place in the absence of sucrose.
This allows us to conclude that (1) sucrose is not increasing the
bril clustering and (2) likely does not aﬀect the ThT staining.
For both of the above hypotheses, an increase of the signal aer
the sonication would indeed have been detected, and such an
increase would be expected to be increasingly signicant at
higher sucrose concentrations. This is not observed in our case.The eﬀect of sucrose on the equilibrium between diﬀerent
species during brillation
The evidence presented in Fig. 1, 2 and 3a could in principle be
due to sucrose-induced changes to the initial structural state
prior to the aggregation. Changes in the structural state will
inuence inter-protein interactions and hence the aggregation
pathway.52,53 However, under the experimental conditions
investigated here, the initial human insulin secondary structure
is not aﬀected by the presence of sucrose (Fig. S2a in ESI†).
SRCD spectra show the same secondary structural content (85%
of a-helices, 10% of random coil and 5% of b-turns) for the
samples at 0%, 20%, and 40% sucrose. This initially suggests
that the expected preferential hydration eﬀect6,54 cannot explain
the observed changes, since the structural state of the starting
material is unaltered.
From the data in Fig. 1 and 2, we can argue that at 40%
sucrose concentration, we have a signicant reduction in bril
formation, even if a potential role of sucrose-layers in altering
the detection of brils cannot be completely ruled out. We used
SRCD to have an indication of the residual monomer concen-
tration at the endpoint of aggregation. Fig. S2b in ESI† shows
the diﬀerent SRCD spectra of the nal state of the brillation in
the presence of various amounts of sucrose. At the end of the
kinetics, the protein is expected to be fully brillated53,55–57 and
should hence show a CD signal typical for b-strands with
a minimum at 216 nm and a maximum around 190 nm (as
shown in Fig. S2b† in the absence of sucrose or with 10%
sucrose). Seemingly, 40% sucrose lowers the bril content,
revealing an increasing occurrence of a-helical secondary
structure. The presence of these structural elements either
reects signicant structural changes in the bril structure, or,
alternatively, a shi in the equilibrium towards a monomeric
state that co-exists with the brils in solution, i.e. a decrease of
the fraction of protein in the bril form. To distinguish between
these options, we centrifuged the bril samples, and the
supernatant is characterized by SRCD (Fig. 4). If the sample is
fully brillated, centrifugation should leave a very low concen-
tration of the monomeric species and small oligomers in the
supernatant, resulting in a low SRCD signal. For concentration
of sucrose > 20%, the supernatant shows an increasingly
intense signal upon increasing the sucrose concentration.
Moreover, the SRCD signal from the soluble fraction sample at
40% sucrose is not statistically diﬀerent from the initial struc-
tural state before brillation (Fig. S2a†). This suggests that
a minor fraction of insulin molecules is converted into brils,
while a larger fraction remains in a native-like soluble state.This journal is © The Royal Society of Chemistry 2017
Fig. 4 SRCD spectra of the supernatant obtained by centrifugation the
ﬁnal product of the ﬁbrillation with diﬀerent percentages of sucrose:
0% (black), 10% (green), 20% (red), 30% (pink) and 40% (blue). The two
black arrows marked the typical minima for alpha-helix secondary
structures.
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View Article OnlineThese results, thus, do highlight that even if the secondary
structures of insulin at diﬀerent sucrose concentrations are
undistinguishable, the preferential hydration (modulated by
the sucrose content) plays a signicant role in stabilizing
a native-like soluble state58 of the molecules that co-exist with
the bril state. Hence, in presence of sucrose the equilibrium
between diﬀerent states (native-like vs. brillation-prone)58 is
likely to be altered, rather than the intrinsic structure of the
soluble starting state.
Data in Fig. 4 thus univocally suggest that the FFV decrease
observed in Fig. 1c is mainly due to a shi of the protein
ensemble towards a less brillation-prone insulin conforma-
tion, determining a dramatic reduction in the fraction of
protein molecules converted into brils.
Earlier studies have shown that lysozyme,4 cytochrome C,7
RNase8 and insulin9 assume a more folded and compact struc-
ture in the presence of sucrose. Indeed, our results are also in
agreement with the presence of a folded and native-like struc-
ture. An explanation for the observed phenomena may be the
fact that sucrose is inuencing both the protein–protein inter-
actions (PPIs) and the diﬀusion of the molecules in solution.
Data in Fig. S2a† show that sucrose does not directly alter the
secondary structure of the insulin molecules. This result means
that changes of PPIs are mainly related to solvent eﬀects rather
than specic changes in the structurally dened protein–
protein interactions.59–61 Sucrose can shield the protein by
transient interactions (i.e. an enthalpic eﬀect), thereby
decreasing the tendency of association,62,63 i.e. an increase in
the repulsion barrier.64–67 In addition to this, in the presence of
sucrose, the viscosity of the solution increases, strongly
aﬀecting the diﬀusion of the protein molecules in solution. This
results in a decrease in the number of attempts for a single
molecule to cross the repulsion barrier and associate to another
molecule,68–70 aﬀecting the lag time of the process. The combi-
nation of these two eﬀects determines a shi of all theThis journal is © The Royal Society of Chemistry 2017equilibria towards the monomeric state, delaying the aggrega-
tion process and the eﬃciency of the conversion into the
aggregated state.Conclusions
We presented an experimental study on insulin amyloid bril
formation in the presence of sucrose. Our data prove that
sucrose delays insulin aggregation kinetics and the extent of
brillation is strongly reduced upon increasing the sucrose
concentration. This is mainly due to a shi of the equilibrium
towards a less brillation-prone monomeric soluble state at
increasing sucrose concentrations, which can be explained by
preferential hydration.58 Moreover, sucrose inuences bril
morphology and clustering, favoring the formation of isolated
and long brils.
Our ndings highlight the role of sucrose not only as
a stabilizer of the native state, as previously suggested in the
literature, but also as a key factor for the formation of
morphologically distinct amyloid brils. This is particularly
relevant in the etiology of amyloidosis. Morphologically
diﬀerent brils can underlie diﬀerent biological activities, such
as diﬀerent toxicity to neuronal cells or deposition patterns in
diseases.71–76 As a consequence, the results reported here point
toward a key role of MCA for in vivo protein aggregation.Acknowledgements
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